CLINICAL TRIALS PROFILE FOR THALITONE
✉ Email this page to a colleague
All Clinical Trials for THALITONE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00591773 ↗ | Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension | Completed | Takeda | Phase 3 | 2007-09-01 | The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with chlorthalidone in treating individuals with essential hypertension, compared to treatment with chlorthalidone alone. |
| NCT01203852 ↗ | Pharmacogenomic Evaluation of Antihypertensive Responses 2 | Completed | National Institute of General Medical Sciences (NIGMS) | Phase 4 | 2010-08-01 | There are many medications available for the treatment of high blood pressure (hypertension), but finding the right one for a specific patient can be challenging. In fact, it is estimated that less than 50% of people with hypertension have their blood pressure under control. The hypothesis is that genetic differences between individuals influence their response to antihypertensive medications. This study is aimed at determining the genetic factors that may influence a person's response to either a beta-blocker or a thiazide diuretic. The hope is that through this research, the investigators may someday be able to use an individual's genetic information to guide the selection of their blood pressure medicine, leading to better control of blood pressure, and less need for the current trial and error process. |
| NCT01203852 ↗ | Pharmacogenomic Evaluation of Antihypertensive Responses 2 | Completed | University of Florida | Phase 4 | 2010-08-01 | There are many medications available for the treatment of high blood pressure (hypertension), but finding the right one for a specific patient can be challenging. In fact, it is estimated that less than 50% of people with hypertension have their blood pressure under control. The hypothesis is that genetic differences between individuals influence their response to antihypertensive medications. This study is aimed at determining the genetic factors that may influence a person's response to either a beta-blocker or a thiazide diuretic. The hope is that through this research, the investigators may someday be able to use an individual's genetic information to guide the selection of their blood pressure medicine, leading to better control of blood pressure, and less need for the current trial and error process. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for THALITONE
Condition Name
Clinical Trial Locations for THALITONE
Trials by Country
Clinical Trial Progress for THALITONE
Clinical Trial Phase
Clinical Trial Sponsors for THALITONE
Sponsor Name
